Abstract
The efficacy of four methods to recover DNA from Papanicolaou (Pap)-stained archival cervical smears for optimal detection of human papillomavirus (HPV) DNA by GP5+/bioGP6+ polymerase chain reaction (PCR) was investigated. Two of the methods were based on proteinase K treatment and two based on treatment with guanidinium thiocyanate (GTC). The quality of the DNA as measured by PCR assays amplifying different sizes of the β-globin gene appeared to be superior for the GTC-based assays. Using competitive β-globin PCR assays, one of the GTC-based, assays, provisionally named High Pure PCR Template Preparation (HPPTP) assay, yielded by far the highest quantity of amplifiable DNA. It allowed the recovery of 2.2 × 105to 3 × 105genome equivalents in smears containing 5 × 105to 20 × 105nucleated cells, indicating a mean efficiency of 26% (range of 15–44%). In contrast, the other methods revealed markedly lower efficiencies varying from 1% to 10%. The use of the HPPTP assay as a reliable processing procedure was validated by demonstrating a complete agreement in HPV detection and 93% agreement in HPV typing between 39 archival Pap-stained and paired fresh-frozen cervical smears. This method was applied to 40 archival smears from ten cervical cancer patients (selected from a group of 200 patients) which had a history of 3–6 smears with the first smear being Pap 1 or 2 taken at least 5 years before cancer was diagnosed. The average time period between the first Pap 1/2 smear that contained the same HPV type as in the corresponding carcinoma and diagnosis of cervical cancer was 12.0 ± 2.9 years. All subsequent smears were invariably positive for the same HPV type which was also found in the cervical cancer biopsy. In conclusion, the HPPTP assay provides a reliable and efficient means to extract DNA from Pap-stained archival cervical smears for the detection of HPV DNA by PCR and would be the method of choice for future HPV analysis of archival Pap-stained cervical smears. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
de Roda Husman AM, Snijders PJF, Stel H, van den Brule AJC, Meijer CJLM and Walboomers JMM (1995) Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72: 412–417
Fleiss JL (1981) Statistical Methods for Rates and Proportions John Wiley: New York
Gall K, Pavicic D, Pavelic J, Audy-Jurkovic S and Pavelic K (1993) PCR amplification of DNA from stained cytological smears. J Clin Pathol 46: 378–379
Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R and Romney S (1995) Peristent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365–1371
IARC (1986) Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293: 659–664
IARC (1995) Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses Vol. 64, Human Papillomaviruses. International Agency for Research on Cancer: Lyon
Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst THJM, Meijer CJLM and Walboomers JMM (1997) A general primer GP5+/6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791–795
Jacobs MV, Walboomers JMM, van Beek J, Voorhorst FJ, Meijer CJLM, van den Brule AJC, Helmerhorst THJM and Snijders PJF (1999) A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer 81: 114–122
Koss LG (1989) The papanicolauou test for cervical cancer detection. A triumph and a tragedy. JAMA 261: 737–743
Meijer CJLM, Rozendaal L, van der Linden JC, Helmerhorst THJM, Voorhorst FJ and Walboomers JMM (1998) Human papillomavirus typing or testing in gynaepathology. Has the time come? Histopathology 33: 83–86
Nobbenhuis MAE, Walboomers JMM, Helmerhorst THJM, Rozendaal L, Remmink AJ, Risse EKJ, van der Linden HC, Voorhorst FJ, Kenemans P and Meijer CJLM (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354: 20–25
Ootmarssen GHvan, Habbema JDF and Ballegooijen Mvan (1992) Predicting mortality from cervical cancer negative smear test results. Br Med J 305: 449–453
Poljak M, Barlic J, Seme K, Avsic-Zupanc T and Zore A (1995) Isolation of DNA from archival Papanicolaou stained cytological smears using a simple salting-out procedure. J Clin Pathol Mol Pathol 48: M55–M56
Puranen M, Saarikski S, Syrjanen K and Syrjanen S (1996) Polymerase chain reaction amplification of human papillomavirus DNA from archival Papanicolaou-stained cervical smears. ACTA Cytol 40: 391–395
Remmink AJ, Walboomers JMM, Helmerhorst THJM, Voorhorst FJ, Rozendaal L, Risse EKJ, Meijer CJLM and Kenemans P (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306–311
Richart RM and Barron BA (1981) Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 25: 543–549
Sepp R, Szabo I, Uda H and Sakamoto H (1994) Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 47: 318–323
Walboomers JMM, de Roda Husman AM, Snijders PJF, Stel HV, Risse EKJ, Helmerhorst THJ, Voorhorst FJ and Meijer CJLM (1995) Human papillomavirus in false-negative smears: implications for screening for cervical cancer. J Clin Pathol 48: 498–503
Walboomers JMM, Snijders PJF and de Roda Husman (1996) Reply to the letter from Poljak et al. Br J Cancer 74: 1509
Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM and Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
zur Hausen H (1994) Molecular pathogenesis of cancer of the uterine cervix and its causation by specific human papillomavirus types. In: Human Pathogenic Papillomaviruses zur Hausen H (ed), pp. 131–156 Springer-Verlag: Berlin
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Jacobs, M., Zielinski, D., Meijer, C. et al. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 82, 1421–1426 (2000). https://doi.org/10.1054/bjoc.1999.1128
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1128
Keywords
This article is cited by
-
Molecular analysis of H&E- and Papanicolau-stained samples—systematic review
Histochemistry and Cell Biology (2020)
-
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
British Journal of Cancer (2007)
-
Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK
British Journal of Cancer (2005)
-
High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum
British Journal of Cancer (2002)